Agilent Technologies, Inc. $A Stock: Investment House LLC Lowers Holdings

Investment House LLC lessened its holdings in Agilent Technologies, Inc. (NYSE:A) by 58.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,400 shares of the medical research company’s stock after selling 4,795 shares during the quarter. Investment House LLC’s holdings in Agilent Technologies were worth $586,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in A. Bank of New York Mellon Corp increased its stake in Agilent Technologies by 87.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock valued at $695,227,000 after buying an additional 2,440,360 shares during the last quarter. Legal & General Group Plc bought a new stake in Agilent Technologies during the 2nd quarter worth about $260,101,000. Bank of America Corp DE acquired a new position in shares of Agilent Technologies during the 2nd quarter worth about $213,269,000. Man Group plc acquired a new position in shares of Agilent Technologies during the 2nd quarter worth about $179,257,000. Finally, Primecap Management Co. CA acquired a new position in shares of Agilent Technologies during the 2nd quarter worth about $176,318,000.

Insiders Place Their Bets

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the firm’s stock in a transaction on Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the completion of the sale, the director owned 4,924 shares of the company’s stock, valued at $745,395.12. This trade represents a 11.41% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on A shares. Wells Fargo & Company lifted their target price on Agilent Technologies from $160.00 to $180.00 and gave the company an “overweight” rating in a research report on Friday, August 28th. Jefferies Financial Group began coverage on Agilent Technologies in a research report on Thursday, July 9th. They set a “hold” rating and a $135.00 price target for the company. HSBC increased their price target on Agilent Technologies from $165.00 to $175.00 and gave the company a “buy” rating in a research report on Tuesday, September 1st. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, October 17th. Finally, Morgan Stanley boosted their price target on Agilent Technologies from $175.00 to $190.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 13th. Seventeen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Agilent Technologies currently has an average rating of “Moderate Buy” and an average price target of $181.00.

Agilent Technologies Price Performance

Shares of NYSE A opened at $172.98 on Friday. The business’s 50 day moving average price is $161.48 and its two-hundred day moving average price is $139.62. The company has a market cap of $48.77 billion, a PE ratio of 28.69, a price-to-earnings-growth ratio of 2.65 and a beta of 1.21. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $179.10.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The firm had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. During the same quarter in the prior year, the company earned $1.37 earnings per share. The business’s revenue for the quarter was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, analysts predict that Agilent Technologies, Inc. will post 6.20 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 28th. Investors of record on Tuesday, October 6th will be issued a dividend of $0.2550 per share. The ex-dividend date of this dividend is Tuesday, October 6th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.6%. Agilent Technologies’s payout ratio is presently 20.08%.

About Agilent Technologies

Agilent Technologies, Inc is a global provider of analytical laboratory instruments, software, services and consumables. The company serves customers in the pharmaceutical, biotechnology, chemical, food, environmental, energy and academic research sectors, as well as diagnostic and clinical laboratories.

Agilent’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic instruments, laboratory automation products, genomic and cell analysis solutions, and related software.